Lewis Bender is the founder of Intensity Therapeutics. Intensity Therapeutics has raised $30M in total funding. Latest round: Growth. Based in Shelton, CT.
Lewis Bender is the President and CEO of Intensity Therapeutics, a late-stage clinical biotechnology company focused on developing first-in-class cancer drugs. He has successfully completed Series A, B, and C financings, raising over $30 million, and holds more than 45 issued patents related to the company's work. Bender previously served as a CEO of another company before founding Intensity Therapeutics to pursue cancer treatment innovation.
Full founder directory · Investor directory · Company funding database · Fundraising library